Subject Matter of the Lobbying Activity
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Promoting the value of an integrated system for research and care for patients with rare progressive neuromuscular diseases like ALS and Spinal Muscular
Atrophy (SMA).
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
- Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
Promoting the value of Biogen Canada's innovative product portfolio, pipeline, and research and products related to biosimilars, depression, ophthalmology, Multiple Sclerosis and
other neuromuscular diseases to address patient needs.
|
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
- Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
|